Published in Gut on October 01, 1995
The urea breath test for Helicobacter pylori. Gut (1994) 2.07
High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut (1995) 1.29
[Qualitative and semiquantitative invasive and noninvasive diagnosis of Helicobacter pylori colonization of gastric mucosa]. Z Gastroenterol (1993) 1.26
Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol (1993) 1.23
Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol (1994) 1.22
Relationships between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion. Z Gastroenterol (1995) 1.18
A topographical relationship between Helicobacter pylori and gastritis: quantitative assessment of Helicobacter pylori in the gastric mucosa. Am J Gastroenterol (1991) 1.13
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66
Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology (1997) 4.59
Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol (1993) 2.73
[Is ulcer disease an infectious disease?]. Dtsch Med Wochenschr (1994) 2.04
[Short guideline for the management of dyspepsia]. Dtsch Med Wochenschr (2004) 2.01
One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1995) 1.93
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology (1996) 1.67
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57
Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. Z Gastroenterol (2003) 1.52
Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut (1994) 1.49
Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol (1997) 1.48
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47
Impact of S3 training courses "Sedation and Emergency Management in Endoscopy for Endoscopy Nurses and Assisting Personnel" on the process and structure quality in gastroenterological endoscopy in practices and clinics - results of a nationwide survey. Z Gastroenterol (2013) 1.43
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40
[The modified 13C-urea breath test in the diagnosis of Helicobacter pylori colonization of the gastric mucosa]. Dtsch Med Wochenschr (1994) 1.39
Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study. Ital J Gastroenterol Hepatol (1998) 1.38
[Helicobacter pylori: from harmless commensal to clinically significant disease factor]. Dtsch Med Wochenschr (1992) 1.38
[Bleeding peptic ulcers--how can recurrent bleeding be prevented?]. Leber Magen Darm (1995) 1.37
Lifestyle factors and symptoms of gastro-oesophageal reflux -- a population-based study. Aliment Pharmacol Ther (2006) 1.36
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol (2001) 1.35
Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol (1994) 1.33
Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut (1995) 1.30
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion (1994) 1.29
[Qualitative and semiquantitative invasive and noninvasive diagnosis of Helicobacter pylori colonization of gastric mucosa]. Z Gastroenterol (1993) 1.26
Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol (1994) 1.22
Acute colonic pseudo-obstruction (Ogilvie's syndrome). Presentation of 14 of our own cases and analysis of 1027 cases reported in the literature. Surg Endosc (1987) 1.16
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther (1996) 1.12
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther (2002) 1.10
Does Helicobacter pylori affect the management of gastroesophageal reflux disease? Am J Gastroenterol (1999) 1.08
Long-term consequences of Helicobacter pylori eradication: clinical aspects. Scand J Gastroenterol Suppl (1996) 1.06
Frequency of idiopathic gastric stasis and intestinal transit disorders in essential dyspepsia. J Clin Gastroenterol (1989) 1.06
Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region. Electrophoresis (1999) 1.02
Are dyspeptic symptoms in patients with Campylobacter pylori-associated type B gastritis linked to delayed gastric emptying? Am J Gastroenterol (1988) 1.02
Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. Scand J Gastroenterol (1996) 1.01
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori]. Leber Magen Darm (1995) 1.00
[Diagnosis of Helicobacter pylori colonization of the gastric mucosa. A prospective comparative study of direct test methods and validation of a new urease test]. Med Klin (Munich) (1991) 1.00
Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia. Am J Gastroenterol (1997) 1.00
Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. Am J Gastroenterol (1999) 0.99
Endoscopy of the terminal ileum. Diagnostic yield in 400 consecutive examinations. Dis Colon Rectum (1985) 0.98
Diffuse gastric antral vascular ectasia: the "watermelon stomach" revisited. Am J Gastroenterol (1987) 0.98
Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus. Dig Dis (1990) 0.97
[S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"]. Z Gastroenterol (2009) 0.96
Colorectal adenomas. Distribution, incidence of malignant transformation, and rate of recurrence. Dis Colon Rectum (1986) 0.96
Validity of a novel biopsy urease test (HUT) and a simplified 13C-urea breath test for diagnosis of Helicobacter pylori infection and estimation of the severity of gastritis. Digestion (1997) 0.95
A novel immunoassay based on monoclonal antibodies for the detection of Helicobacter pylori antigens in human stool. Z Gastroenterol (2001) 0.94
Gastrointestinal metastases of breast carcinoma. Gastrointest Endosc (1993) 0.92
[Prevalence of gastro-oesophageal reflux disease in general practice]. Dtsch Med Wochenschr (2002) 0.92
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study. Aliment Pharmacol Ther (2009) 0.91
Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut (1997) 0.90
Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study. Ital J Gastroenterol Hepatol (1999) 0.88
[Upper intestinal endoscopy in 188 bronchial cancer patients and 118 breast cancer patients with abdominal symptoms. The GI Metastases Study Group]. Med Klin (Munich) (1992) 0.88
Gallbladder wall thickening: a frequent finding in various nonbiliary disorders--a prospective ultrasonographic study. J Clin Ultrasound (1987) 0.87
Validity of a Helicobacter pylori stool antigen assay for the assessment of H. pylori status following eradication therapy. Eur J Gastroenterol Hepatol (2001) 0.87
Focal inflammatory infiltrations in gastric biopsy specimens are suggestive of Crohn's disease. Crohn's Disease Study Group, Germany. Scand J Gastroenterol (1997) 0.86
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa? Dig Dis (2004) 0.86
[Guidelines of the German Society of Digestive and Metabolic Diseases for treatment of dyspepsia]. Z Gastroenterol (2001) 0.86
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther (2008) 0.86
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. Aliment Pharmacol Ther (2003) 0.86
Cure of Helicobacter pylori-associated ulcer disease through eradication. Baillieres Best Pract Res Clin Gastroenterol (2000) 0.85
Role of aging in the expression of Helicobacter pylori gastritis in the antrum, corpus, and cardia. Scand J Gastroenterol (1999) 0.85
[S2k guidelines diverticular disease/diverticulitis]. Z Gastroenterol (2014) 0.85
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Aliment Pharmacol Ther (2006) 0.84
Toward an optimal treatment of Helicobacter pylori-positive peptic ulcers. Am J Gastroenterol (1995) 0.84
Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease. Dig Dis Sci (1994) 0.84